Bioenergetics and metabolism: a bench to bedside perspective

被引:25
|
作者
Swerdlow, Russell H. [1 ,2 ,3 ,4 ]
机构
[1] Univ Kansas, Alzheimers Dis Ctr, Kansas City, KS USA
[2] Univ Kansas, Med Ctr, Dept Neurol, 3901 Rainbow Blvd, Kansas City, KS 66160 USA
[3] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66103 USA
[4] Univ Kansas, Med Ctr, Dept Biochem & Mol Biol, Kansas City, KS USA
关键词
Alzheimer's disease; bioenergetics; metabolism; mitochondria; neurodegeneration; AMYLOID PRECURSOR PROTEIN; MITOCHONDRIAL CASCADE HYPOTHESIS; COMPLEX-I DEFICIENCY; ALZHEIMERS-DISEASE; OXIDATIVE STRESS; PARKINSONS-DISEASE; CREATINE SUPPLEMENTATION; CYTOCHROME-OXIDASE; ENERGY-METABOLISM; SKELETAL-MUSCLE;
D O I
10.1111/jnc.13509
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Metabolism' refers to the vast collection of chemical processes that occur within a living organism. Within this broad designation, one can identify metabolism events that relate specifically to energy homeostasis, whether they occur at the subcellular, cellular, organ, or whole organism level. This review operationally refers to this type of metabolism as energy metabolism' or bioenergetics.' Changes in energy metabolism/bioenergetics have been linked to brain aging and a number of neurodegenerative diseases, and research suggests mitochondria may uniquely contribute to this. Interventions that manipulate energy metabolism/bioenergetic function and mitochondria may have therapeutic potential and efforts intended to accomplish this are playing out at basic, translational, and clinical levels. This review follows evolving views of energy metabolism's role in neurodegenerative diseases but especially Alzheimer's disease, with an emphasis on the bench-to-bedside process whose ultimate goal is to develop therapeutic interventions. It further considers challenges encountered during this process, which include linking basic concepts to a medical question at the initial research stage, adapting conceptual knowledge gained to a disease-associated application in the translational stage, extending what has been learned to the clinical arena, and maintaining support for the research at each of these fundamentally linked but functionally distinct stages.
引用
收藏
页码:126 / 135
页数:10
相关论文
共 50 条
  • [41] From Bench to Bedside
    不详
    EUROPEAN HEART JOURNAL, 2018, 39 (32) : 2922 - 2923
  • [42] From bench to bedside
    Alberti, A
    JOURNAL OF HEPATOLOGY, 2005, 42 (03) : 301 - 301
  • [43] From bench to bedside
    Verdant, Colin L.
    CRITICAL CARE, 2012, 16 (04):
  • [44] From bench to bedside
    Jaeger, TM
    Knoll, MR
    Sturm, JW
    Winkler, M
    Post, S
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1999, 124 (05) : 121 - 123
  • [45] Bench reaches the bedside
    Stueber, F.
    ANAESTHESIST, 2008, 57 (04): : 325 - 325
  • [46] From bedside to bench
    Henein, M
    O'Callaghan, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (05) : 928 - 928
  • [47] USA - Bedside to bench
    Hirsch, J
    CLINICAL AND INVESTIGATIVE MEDICINE, 2005, 28 (01): : 9 - 11
  • [48] From bench to bedside
    Trümper, L
    MEDIZINISCHE KLINIK, 2005, 100 (01) : 53 - 53
  • [49] Pharmacogenomics: bench to bedside
    Richard Weinshilboum
    Liewei Wang
    Nature Reviews Drug Discovery, 2004, 3 : 739 - 748
  • [50] Bench, bedside, and balance
    Jauhar, Sameer
    Young, Allan H.
    JOURNAL OF PSYCHOPHARMACOLOGY, 2022, 36 (02) : 129 - 130